Offering the benefits of real-time collaboration and integrated connectivity, the portable ultrasound device may be utilized in a variety of clinical settings ranging from cardiology to obstetrics and gynecology.
The Philips Ultrasound 5000 Compact Series, which reportedly facilitates real-time collaboration and streamlined workflows, has garnered 510(k) clearance from the Food and Drug Administration (FDA).
Philips noted the portable device provides a combination of enhanced image quality and remote consultation capability (via Philips Ultrasound Collaboration Live tele-ultrasound) that facilitates clinical decision support with mobile efficiency. In addition to general imaging and utility in the obstetrics and gynecology fields, Philips said the Ultrasound 5000 Compact Series enables timely assessments in cardiology and point-of-care ultrasonography.
“Globally, clinicians are faced with increasing pressures to deliver higher patient throughput for quick, confident diagnoses via ultrasound exams while receiving more and more requests to perform rapid ultrasound exams at the bedside,” noted Matthijs Groot Wassink, the general manager of Point-of-Care Ultrasound at Philips. “Until now, portable ultrasound systems have typically meant decreased performance, lack of advanced features, and lower grade image quality. With this clearance for our next-generation portable Philips Ultrasound 5000 Compact Series, clinicians now have the ability to make quicker and more confident diagnoses.”
In order to facilitate consistency and efficiency with use of the Ultrasound 5000 Compact Series, Philips said the new portable device offers the same features, touch screens and user interfaces as the company’s EPIQ and Affiniti ultrasound systems.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.
New Literature Review Finds ChatGPT Effective in Radiology in 84 Percent of Studies
April 29th 2024While noting a variety of pitfalls with the chatbot ranging from hallucinations to improper citations, the review authors found the use of ChatGPT in radiology demonstrated “high performance” in 37 out of 44 studies.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.